The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Viral hepatitis and liver cancer: the case of hepatitis C
Open accessAbstract
Chronic infection with the hepatitis C virus (HCV) is a major risk factor for the development of hepatocellular carcinoma (HCC) worldwide. The pathogenesis of HCC in HCV infection has extensively been analysed. Hepatitis C virus-induced chronic inflammation and the effects of cytokines in the development of fibrosis and liver cell proliferation are considered as one of the major pathogenic mechanisms. Increasing experimental evidence suggests that HCV contributes to HCC by directly modulating pathways that promote the malignant transformation of hepatocytes. Hepatitis C virus is an RNA virus that does not integrate into the host genome but HCV proteins interact with many host-cell factors well beyond their roles in the viral life cycle and are involved in a wide range of activities, including cell signaling, transcription, cell proliferation, apoptosis, membrane rearrangements, vesicular trafficking and translational regulation. At least four of the HCV gene products, namely HCV core, NS3, NS4B and NS5A, have been shown to exhibit transformation potential in tissue culture and several potentially oncogenic pathways have been shown to be altered by the expression of HCV proteins. Both HCV core and NS5A induce the accumulation of wild-type beta-catenin and the Wnt-beta-catenin pathway emerges as a common target for HCV (and HBV) in human HCCs, also independently from axin/beta-catenin gene mutations. Induction of both endoplasmic reticulum stress and oxidative stress by HCV proteins might also contribute to HCV transformation. Most of the putative transforming functions of the HCV proteins have been defined in artificial cellular systems, which may not be applicable to HCV infection in vivo, and still need to be established in relevant infection and disease models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Kaufman, R. J. (1999) · Genes & Development · doi:10.1101/gad.13.10.1211 · Cited by 2,248
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Epidemiology of Primary Liver Cancer
Bosch, F., Ribes, J., & Borràs, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007117 · Cited by 958
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., & Weinman, S. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.30983 · Cited by 926
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Gene Expression Patterns in Human Liver Cancers
Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., Lai, K.-M., Ji, J., Dudoit, S., Ng, I. O. L., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0023 · Cited by 878
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Gale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease
Cacciola, I., Pollicino, T., Squadrito, G., Cerenzia, G., Orlando, M. E., & Raimondo, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410104 · Cited by 666
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1200 · Cited by 658
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608299 · Cited by 639
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
Moriya, K., Matsuura, Y., Miyamura, T., Koike, K., Shintani, Y., Ishibashi, K., Fujie, H., & Yotsuyanagi, H. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-7-1527 · Cited by 624
Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597 · cited 3×
“It is noteworthy that the HBV-encoded protein HBx also activates the b-catenin pathway through an ERKmediated inactivation of GSK-3b (Ding et al., 2005).”
BackgroundInfluentialGong, G., Waris, G., Tanveer, R., & Siddiqui, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171311298 · Cited by 584
Perlemuter, G., Sabile, A., Letteron, P., Vona, G., Topilco, A., Chrétien, Y., Koike, K., Pessayre, D., Chapman, J., Barba, G., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0396com · Cited by 584
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
The p53/p63/p73 family of transcription factors: overlapping and distinct functions
Levrero, M., Laurenzi, V. D., Costanzo, A., Sabatini, S., Gong, J., Wang, J. Y. J., & Melino, G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1661 · Cited by 565
Self-citationTorbenson, M., & Thomas, D. L. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00345-6 · Cited by 533
Increase in primary liver cancer in the UK, 1979–94
Taylor-Robinson, S. D., Foster, G. R., Arora, S., Hargreaves, S., & Thomas, H. C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63789-0 · Cited by 506
Aguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Lerat, H., Honda, M., Beard, M. R., Loesch, K., Sun, J., Yang, Y., Okuda, M., Gosert, R., Xiao, S., Weinman, S. A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31001 · Cited by 473
Crotta, S., Stilla, A., Wack, A., D'Andrea, A., Nuti, S., D'Oro, U., Mosca, M., Filliponi, F., Brunetto, R. M., Bonino, F., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011124 · Cited by 471
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Tseng, C.-T. K., & Klimpel, G. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011145 · Cited by 447
Effect of Alpha Interferon on the Hepatitis C Virus Replicon
Guo, J.-T., Bichko, V. V., & Seeger, C. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8516-8523.2001 · Cited by 443
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
Pollicino, T., Squadrito, G., Cerenzia, G., Cacciola, I., Raffa, G., Craxı̀, A., Farinati, F., Missale, G., Smedile, A., Tiribelli, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.048 · Cited by 427
Ray, R. B., Lagging, L. M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 403
The Unfolding Tale of the Unfolded Protein Response
Ma, Y., & Hendershot, L. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00623-7 · Cited by 401
Expression of vascular endothelial growth factor in human hepatocellular carcinoma
Yamaguchi, R., Yano, H., Iemura, A., Ogasawara, S., Haramaki, M., & Kojiro, M. (1998) · Hepatology · doi:10.1002/hep.510280111 · Cited by 397
Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., & Lai, M. M. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3691-3697.1998 · Cited by 387
Ikeda, M., Yi, M., Li, K., & Lemon, S. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2997-3006.2002 · Cited by 383
Brass, V., Bieck, E., Montserret, R., Wölk, B., Hellings, J. A., Blum, H. E., Penin, F., & Moradpour, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111289200 · Cited by 365
Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture
Pietschmann, T., Lohmann, V., Kaul, A., Krieger, N., Rinck, G., Rutter, G., Strand, D., & Bartenschlager, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4008-4021.2002 · Cited by 364
Balachandran, S., Kim, C. N., Yeh, W.-C., Mak, T. W., Bhalla, K., & Barber, G. N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6888 · Cited by 355
Bi-allelic inactivation of TCF1 in hepatic adenomas
Bluteau, O., Jeannot, E., Bioulac-Sage, P., Marqués, J. M., Blanc, J.-F., Bui, H., Beaudoin, J.-C., Franco, D., Balabaud, C., Laurent-Puig, P., et al. (2002) · Nature Genetics · doi:10.1038/ng1001 · Cited by 353
Marusawa, H., Hijikata, M., Chiba, T., & Shimotohno, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4713-4720.1999 · Cited by 345
Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., & Hahn, Y. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10323 · Cited by 333
Polyak, S. J., Khabar, K. S. A., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., Levy, D. E., Mukaida, N., & Gretch, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6095-6106.2001 · Cited by 323
Ohata, K., Hamasaki, K., Toriyama, K., Matsumoto, K., Saeki, A., Yanagi, K., Abiru, S., Nakagawa, Y., Shigeno, M., Miyazoe, S., et al. (2003) · Cancer · doi:10.1002/cncr.11427 · Cited by 322
Trends in primary liver cancer
Deuffic, S., Poynard, T., Buffat, L., & Valleron, A.-J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78179-4 · Cited by 316
Shi, S. T., Polyak, S. J., Tu, H., Taylor, D. R., Gretch, D. R., & Lai, M. M. C. (2002) · Virology · doi:10.1006/viro.2001.1225 · Cited by 309
Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., et al. (1996) · Hepatology · doi:10.1002/hep.510230309 · Cited by 307
Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells
Sakamuro, D., Furukawa, T., & Takegami, T. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3893-3896.1995 · Cited by 306
Higashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R. J., Arii, S., & Fujita, J. (2000) · Nature Medicine · doi:10.1038/71600 · Cited by 299
Transcriptional Repression of p53 Promoter by Hepatitis C Virus Core Protein
Ray, R. B., Steele, R., Meyer, K., & Ray, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.10983 · Cited by 279
Comprehensive allelotyping of human hepatocellular carcinoma
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A., & Dejean, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201136 · Cited by 274
Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame
WALEWSKI, J. L., KELLER, T. R., STUMP, D. D., & BRANCH, A. D. (2001) · RNA · doi:10.1017/s1355838201010111 · Cited by 268
Fibrosis and disease progression in hepatitis C
Marcellin, P., Asselah, T., & Boyer, N. (2002) · Hepatology · doi:10.1002/hep.1840360707 · Cited by 267
Tardif, K. D., Mori, K., & Siddiqui, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7453-7459.2002 · Cited by 262
Lerat, H., Rumin, S., Habersetzer, F., Berby, F., Trabaud, M.-A., Trépo, C., & Inchauspé, G. (1998) · Blood · doi:10.1182/blood.v91.10.3841 · Cited by 261
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
Tanaka, S., Mori, M., Sakamoto, Y., Makuuchi, M., Sugimachi, K., & Wands, J. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4891 · Cited by 256
Majumder, M., Ghosh, A. K., Steele, R., Ray, R., & Ray, R. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1401-1407.2001 · Cited by 255
Bataller, R., Paik, Y.-H., Lindquist, J. N., Lemasters, J. J., & Brenner, D. A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.018 · Cited by 252
Gale, M., Kwieciszewski, B., Dossett, M., Nakao, H., & Katze, M. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6506-6516.1999 · Cited by 250
Hepatitis C Virus RNA Polymerase and NS5A Complex with a SNARE-like Protein
Tu, H., Gao, L., Shi, S. T., Taylor, D. R., Yang, T., Mircheff, A. K., Wen, Y., Gorbalenya, A. E., Hwang, S. B., & Lai, M. M. C. (1999) · Virology · doi:10.1006/viro.1999.9893 · Cited by 249
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.009 · Cited by 249
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis
Lan, K.-H., Sheu, M.-L., Hwang, S.-J., Yen, S.-H., Chen, S.-Y., Wu, J.-C., Wang, Y.-J., Kato, N., Omata, M., Chang, F.-Y., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205589 · Cited by 245
Sensitization to Fas-Mediated Apoptosis by Hepatitis C Virus Core Protein
Ruggieri, A., Harada, T., Matsuura, Y., & Miyamura, T. (1997) · Virology · doi:10.1006/viro.1996.8420 · Cited by 244
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Tan, S.-L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J., & Katze, M. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5533 · Cited by 233
Ming, L., Thorgeirsson, S. S., Gail, M. H., Lu, P., Harris, C. C., Wang, N., Shao, Y., Wu, Z., Liu, G., Wang, X., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36366 · Cited by 233
Reducing Liver Cancer--Global Control of Aflatoxin
Henry, S. H., Bosch, F. X., Troxell, T. C., & Bolger, P. M. (1999) · Science · doi:10.1126/science.286.5449.2453 · Cited by 227
Street, A., Macdonald, A., Crowder, K., & Harris, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312245200 · Cited by 220
Sun, Z., Lu, P., Gail, M. H., Pee, D., Zhang, Q., Ming, L., Wang, J., Wu, Y., Liu, G., Wu, Y., et al. (1999) · Hepatology · doi:10.1002/hep.510300204 · Cited by 220
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor
Matsumoto, M., Hsieh, T. Y., Zhu, N., VanArsdale, T., Hwang, S. B., Jeng, K. S., Gorbalenya, A. E., Lo, S. Y., Ou, J. H., Ware, C. F., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1301-1309.1997 · Cited by 218
Interaction between hepatitis C virus proteins and host cell factors
Tellinghuisen, T. L., & Rice, C. M. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00341-7 · Cited by 213
Constitutive activation of nuclear factor ?B in hepatocellular carcinoma
Tai, D.-I., Tsai, S.-L., Chang, Y.-H., Huang, S.-N., Chen, T.-C., Chang, K. S. S., & Liaw, Y.-F. (2000) · Cancer · doi:10.1002/1097-0142(20001201)89:11<2274::aid-cncr16>3.0.co;2-2 · Cited by 201
Hepatitis C Virus Core Protein Interacts with a Human DEAD Box Protein DDX3
Owsianka, A. M., & Patel, A. H. (1999) · Virology · doi:10.1006/viro.1999.9659 · Cited by 196
Tai, D.-I., Tsai, S.-L., Chen, Y.-M., Chuang, Y.-L., Peng, C.-Y., Sheen, I.-S., Yeh, C.-T., Chang, K. S., Huang, S.-N., Kuo, G. C., et al. (2000) · Hepatology · doi:10.1002/hep.510310316 · Cited by 191
Genetic Aspects of Hepatocellular Carcinogenesis
Ozturk, M. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007113 · Cited by 186
Jordan, R., Wang, L., Graczyk, T. M., Block, T. M., & Romano, P. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9588-9599.2002 · Cited by 185
Mitsuhashi, N., Shimizu, H., Ohtsuka, M., Wakabayashi, Y., Ito, H., Kimura, F., Yoshidome, H., Kato, A., Nukui, Y., & Miyazaki, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50204 · Cited by 183
Sumida, Y., Nakashima, T., Yoh, T., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Sakamoto, Y., Okanoue, T., Kashima, K., Nakamura, H., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80013-6 · Cited by 182
Regulation of PKR and IRF-1 during hepatitis C virus RNA replication
Pflugheber, J., Fredericksen, B., Sumpter, R., Wang, C., Ware, F., Sodora, D. L., & Gale, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062055699 · Cited by 181
High frequency of p16INK4A gene alterations in hepatocellular carcinoma
Liew, C. T., Li, H.-M., Lo, K.-W., Leow, C. K., Chan, J. Y., Hin, L. Y., Lau, W. Y., Lai, P. B. S., Lim, B. K., Huang, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202359 · Cited by 180
Blindenbacher, A., Duong, F. H. T., Hunziker, L., Stutvoet, S. T. D., Wang, X., Terracciano, L., Moradpour, D., Blum, H. E., Alonzi, T., Tripodi, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00290-7 · Cited by 178
Sabile, A., Perlemuter, G., Bono, F., Kohara, K., Demaugre, F., Kohara, M., Matsuura, Y., Miyamura, T., Bréchot, C., & Barba, G. (1999) · Hepatology · doi:10.1002/hep.510300429 · Cited by 173
Müller, M., Schilling, T., Sayan, A. E., Kairat, A., Lorenz, K., Schulze-Bergkamen, H., Oren, M., Koch, A., Tannapfel, A., Stremmel, W., et al. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401774 · Cited by 171
Identification of Differentially Expressed Genes in Hepatocellular Carcinoma With Cdna Microarrays
Shirota, Y., Kaneko, S., Honda, M., Kawai, H. F., & Kobayashi, K. (2001) · Hepatology · doi:10.1053/jhep.2001.23003 · Cited by 170
Brunt, E. M., Neuschwander-Tetri, B. A., Oliver, D., Wehmeier, K. R., & Bacon, B. R. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.017 · Cited by 167
Nam, S. W., Park, J. Y., Ramasamy, A., Shevade, S., Islam, A., Long, P. M., Park, C. K., Park, S. E., Kim, S. Y., Lee, S. H., et al. (2005) · Hepatology · doi:10.1002/hep.20878 · Cited by 167
Hepatitis C Virus Core Protein Binds to a DEAD Box RNA Helicase
Mamiya, N., & Worman, H. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15751 · Cited by 166
Fukutomi, T., Zhou, Y., Kawai, S., Eguchi, H., Wands, J. R., & Li, J. (2005) · Hepatology · doi:10.1002/hep.20668 · Cited by 166
Molecular pathogenesis of hepatocellular carcinoma
Wong, C., & Ng, I. O. L. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01637.x · Cited by 165
Hepatitis C Virus Core Protein Interacts with Cellular Putative RNA Helicase
You, L.-R., Chen, C.-M., Yeh, T.-S., Tsai, T.-Y., Mai, R.-T., Lin, C.-H., & Lee, Y.-H. W. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2841-2853.1999 · Cited by 164
Pathogenesis of hepatocellular carcinoma
Moradpour, D., & Blum, H. E. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200505000-00002 · Cited by 164
Otsuka, M., Kato, N., Lan, K.-H., Yoshida, H., Kato, J., Goto, T., Shiratori, Y., & Omata, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000578200 · Cited by 164
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Street, A., Macdonald, A., McCormick, C. J., & Harris, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5006-5016.2005 · Cited by 157
Hayashi, J., Aoki, H., Kajino, K., Moriyama, M., Arakawa, Y., & Hino, O. (2000) · Hepatology · doi:10.1053/jhep.2000.19343 · Cited by 147
Cytokine regulation of liver development
Kinoshita, T., & Miyajima, A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00323-3 · Cited by 147
Activation of p53 Tumor Suppressor by Hepatitis C Virus Core Protein
Lu, W. Y., Lo, S., Chen, M., Wu, K.-J., Fung, Y. K., & Ou, J. J. (1999) · Virology · doi:10.1006/viro.1999.9979 · Cited by 140
Hepatitis C Virus Core Protein Interacts with Heterogeneous Nuclear Ribonucleoprotein K
Hsieh, T., Matsumoto, M., Chou, H.-C., Schneider, R. J., Hwang, S. B., Lee, A. S., & Lai, M. M. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17651 · Cited by 139
Functional Genomics of Hepatocellular Carcinoma
Thorgeirsson, S. S., Lee, J., & Grisham, J. W. (2006) · Hepatology · doi:10.1002/hep.21063 · Cited by 137
Patil, M. A., Chua, M., Pan, K., Lin, R., Lih, C., Cheung, S., Ho, C., Li, R., Fan, S.-T., Cohen, S. N., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208479 · Cited by 137
Chen, C., & Chen, D. (2002) · Hepatology · doi:10.1053/jhep.2002.37084 · Cited by 137
Squadrito, G., Pollicino, T., Cacciola, I., et al. (2006) · Cancer · doi:10.1002/cncr.21702 · Cited by 136
Transforming growth factor‐ß1 in chronic hepatitis C
Nelson, D. R., González‐Peralta, R. P., Qian, K., Xu, Y., Marousis, C. G., Davis, G. L., & Lau, J. Y. N. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00124.x · Cited by 134
Giambartolomei, S., Covone, F., Levrero, M., & Balsano, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204372 · Cited by 133
Self-citationModulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A
Arima, N., Kao, C., Licht, T., Padmanabhan, R., Sasaguri, Y., & Padmanabhan, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008329200 · Cited by 131
Breuhahn, K., Vreden, S., Haddad, R., Beckebaum, S., Stippel, D. L., Flemming, P., Nussbaum, T., Caselmann, W. H., Haab, B. B., & Schirmacher, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0292 · Cited by 129
Waris, G., Tardif, K. D., & Siddiqui, A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01300-x · Cited by 128
Histopathology of liver cancers
Kojiro, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.10.007 · Cited by 126
Hepatitis C virus core protein‐induced loss of LZIP function correlates with cellular transformation
Jin, D., Wang, H., Zhou, Y., Chun, A. C. S., Kibler, K. V., Hou, Y., Kung, H., & Jeang, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.729 · Cited by 124
Erhardt, A., Hassan, M., Heintges, T., & Häussinger, D. (2002) · Virology · doi:10.1006/viro.2001.1227 · Cited by 123
Santoni‐Rugiu, E., Preisegger, K., Kiss, A., Audolfsson, T., Shiota, G., Schmidt, E. V., & Thorgeirsson, S. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9577 · Cited by 121
Molecular Pathogenesis of Hepatocellular Carcinoma
McKillop, I. H., Moran, D. M., Jin, X., & Koniaris, L. G. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.04.013 · Cited by 115
Majumder, M., Ghosh, A. K., Steele, R., Zhou, X., Phillips, N. J., Ray, R., & Ray, R. B. (2002) · Virology · doi:10.1006/viro.2001.1309 · Cited by 114
Zhao, L., Wang, L., Ren, H., Cao, J., LI, L., KE, J., & QI, Z. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.12.024 · Cited by 114
Machida, K., Tsukiyama–Kohara, K., Seike, E., Toné, S., Shibasaki, F., Shimizu, M., Takahashi, H., Hayashi, Y. K., Funata, N., Taya, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010137200 · Cited by 114
Neo, S. Y., Leow, C. K., Vega, V. B., Long, P. M., Islam, A. F. M., Lai, P. B. S., Liu, E. T., & Ren, E. C. (2004) · Hepatology · doi:10.1002/hep.20105 · Cited by 111
Lee, J., & Thorgeirsson, S. S. (2002) · Hepatology · doi:10.1053/jhep.2002.33165 · Cited by 111
Wakita, T., Taya, C., Katsume, A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9001 · Cited by 103
Zhu, N., Ware, C. F., & Lai, M. M. C. (2001) · Virology · doi:10.1006/viro.2001.0896 · Cited by 99
Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor
Ishido, S., & Hotta, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01312-x · Cited by 96
Delpuech, O., Trabut, J., Carnot, F., Feuillard, J., Bréchot, C., & Kremsdorf, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205392 · Cited by 95
Joo, M., Hahn, Y. S., Kwon, M., Sadikot, R. T., Blackwell, T. S., & Christman, J. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7648-7657.2005 · Cited by 95
Park, J., Yang, J. M., & Min, M.-K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1999 · Cited by 94
Satoh, S., Hirota, M., Noguchi, T., et al. (2000) · Virology · doi:10.1006/viro.2000.0287 · Cited by 78
Vossio, S., Palescandolo, E., Pediconi, N., Moretti, F., Balsano, C., Levrero, M., & Costanzo, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205465 · Cited by 78
Self-citationPhysical and functional interaction between HCV core protein and the different p73 isoforms
Alisi, A., Giambartolomei, S., Cupelli, F., Merlo, P., Fontemaggi, G., Spaziani, A., & Balsano, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206333 · Cited by 73
Qadri, I., Iwahashi, M., & Simon, F. R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00315-4 · Cited by 72
Nuclear Localization Signals in the Core Protein of Hepatitis C Virus
Chang, S., Yen, J.-H., Kang, H., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2804 · Cited by 72
Disson, O., Haouzi, D., Desagher, S., Loesch, K., Hahne, M., Kremer, E. J., Jacquet, C., Lemon, S. M., Hibner, U., & Lerat, H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.005 · Cited by 72
Nonstructural Protein 5A of Hepatitis C Virus Inhibits the Function of Karyopherin β3
Chung, K. M., Lee, J., Kim, J., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5233-5241.2000 · Cited by 70
HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation
Cho, J., Baek, W., Yang, S.-H., Chang, J., Sung, Y. C., & Suh, M. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00137-3 · Cited by 67
Soo, H. M., Demo, A. G., Hong, W., Tan, Y. H., Tan, Y., Goh, P., Lim, S. G., & Lim, S. P. (2002) · Virology · doi:10.1006/viro.2002.1617 · Cited by 59
Expression of hepatitis C virus non‐structural 5A protein in the liver of transgenic mice
Majumder, M., Steele, R., Ghosh, A. K., Zhou, X., Thornburg, L. P., RAY, R. K., Phillips, N. J., & Ray, R. B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01337-1 · Cited by 51
Complex Formation between Hepatitis C Virus Core Protein and p21Waf1/Cip1/Sdi1
Wang, F., Yoshida, I., Takamatsu, M., Ishido, S., Fujita, T., Oka, K., & Hotta, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2970 · Cited by 50
Neuman, M. G., Benhamou, J., Bourlière, M., Ibrahim, A., Malkiewicz, I. M., Asselah, T., Martinot-Peignoux, M., Shear, N. H., Katz, G. G., Akremi, R., et al. (2002) · Cytokine · doi:10.1006/cyto.2001.0997 · Cited by 47
Hepatitis C virus structural proteins induce liver cell injury in transgenic mice
Honda, A., Arai, Y., Hirota, N., Sato, T., Ikegaki, J., Koizumi, T., Hatano, M., Kohara, M., Moriyama, T., Imawari, M., et al. (1999) · Journal of Medical Virology · Cited by 46
Fukuda, K., Tsuchihara, K., Hijikata, M., Nishiguchi, S., Kuroki, T., & Shimotohno, K. (2001) · Hepatology · doi:10.1053/jhep.2001.20794 · Cited by 44
Borowski, P., Wiesch, J. S. Z., Resch, K., Feucht, H. H., Laufs, R., & SCHMITZ, H. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30722 · Cited by 37
The molecular pathogenesis of hepatocellular carcinoma
Moradpour, D., & Wands, J. R. (1994) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1994.tb00058.x · Cited by 33
Borowski, P., Kühl, R., Laufs, R., Wiesch, J. S. Z., & Heiland, M. (1999) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)00007-4 · Cited by 33
Cited by
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Assembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
Viruses associated with human cancer
McLaughlin-Drubin, M. E., & Munger, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.005 · Cited by 406
That which does not kill me makes me stronger: adapting to chronic ER stress
Rutkowski, D. T., & Kaufman, R. J. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.003 · Cited by 398
Metadata
- Authors
- Levrero, M.
- Venue
- Oncogene
- Published
- 2006-06-26
- Volume
- 25
- Issue
- 27
- Pages
- 3834-3847
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2127151069
- Cited by
- 404
- References
- 148
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.